CVS/pharmacy promotes in-store fundraising campaign to battle lung cancer at Fenway Park
WOONSOCKET, R.I. — A Kensington, N.H., resident and her family recently took the field with CVS Caremark and American Lung Association at Fenway Park to inspire fans to join Lung Force. This year, CVS/pharmacy is teaming up with the American Lung Association for a new in-store fundraising campaign to support Lung Force, a recently launched initiative that strives to make lung cancer in women a public health priority.
Since June 1 and through June 29, CVS/pharmacy customers can contribute to Lung Force at the register in stores nationwide or online at www.cvs.com/lung, with all proceeds going to support the movement.
Jane Bannister of Kensington, N.H., showed her support for the campaign while encouraging women to stand together against lung cancer — the No. 1 cancer killer of women — by throwing out the first pitch prior to the Boston Red Sox versus Minnesota Twins game on Monday. Joining her on the pitcher’s mound was Eileen Howard Boone, SVP of corporate social responsibility and philanthropy at CVS Caremark. The pre-game tradition included a reminder to fans that there is still time to donate to Lung Force at CVS/pharmacy stores across the country.
Bannister’s mother lost her life in 2008 after a three-year battle with lung cancer. Bannister has shared her story on the Lung Force website to raise awareness and help other women and their families. Her father also lost his life to lung cancer in 1991. She was cheered on at Fenway Park by her daughter, Catherine, a junior at Exeter High School in Exeter, N.H., her brother Ed Friedlander, and his son, Colton, age 6.
Others providing support to Bannister at Fenway Park included VP of the American Lung Association Alana Burns and president and CEO of the American Lung Association Northeast Jeff Seyler.
CVS/pharmacy announced the in-store fundraising campaign in early June to help fight the No. 1 cancer killer of women. In addition to making lung cancer in women a public health priority, Lung Force is seeking to drive policy change and increase research funding. CVS Caremark is the national presenting sponsor of Lung Force.
“Our new campaign aligns well with our purpose of helping people on their path to better health and our commitment to partnering with community organizations to help more people lead tobacco-free lives,” said Howard Boone. “Lung Force is raising awareness about a critical issue for women and their loved ones. Our in-store fundraising will engage our colleagues and customers in raising awareness and critical funds for lung cancer research.”
CVS Caremark colleagues also are engaging in the Lung Force initiative by participating in local Lung Force events across the country. Earlier this year, CVS Caremark announced its decision to remove tobacco from its more than 7,600 retail stores by Oct. 1, 2014, making them the first national retail pharmacy chain in the country to do so.
CHPA praises Michigan legislature that would curb meth-related crimes
WASHINGTON — The Consumer Healthcare Products Association applauded the Michigan legislature, which seeks to address the state’s methamphetamine problem by targeting meth criminals. The Michigan House and Senate passed a package of bills authored by Sen. John Proos as well as Reps. Amanda Price, Bob Genetski, and Aric Nesbitt that will equip law enforcement officials with tools to crack down on meth-related crime.
The legislation includes a meth offender block list and a measure that will broaden the criminal penalty for "smurfing," where individuals purchase pseudoephedrine-containing medicines on behalf of a meth cook.
"Michigan lawmakers scored a major victory last week by passing this comprehensive package of anti-meth bills," said Carlos Gutierrez, senior director and head of state government affairs for the Consumer Healthcare Products Association. "Leaders like Senator Proos and Representatives Price, Genetski and Nesbitt should be commended for sponsoring balanced policies that target criminals without burdening responsible law-abiding consumers. Moreover, these programs are proven to work. Other states that have adopted similar policies — such as a statewide meth offender registry — have seen drastic reductions in meth lab incidents since their inception. Oklahoma for example, saw a more than 50% reduction in the number of meth lab incidents just a year after passing a similar measure."
Actavis confirms court ruling in generic patent suit
DUBLIN — Actavis confirmed that the U.S. District Court for the District of Delaware found certain claims of U.S. Patent Nos. 6,335,031 and 6,316,023 valid and infringed by the company’s rivastigmine transdermal system, a generic version of Exelon Patch from Novartis.
Actavis said it is reviewing the court’s decision and weighing all available options, including an appeal.
Exelon Patch is used to treat patients with mild to moderate dementia associated with Alzheimer’s or Parkinson’s disease. Actavis’ abbreviated new drug application for its generic version of Exelon Patch is pending with the Food and Drug Administration.